These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 36992356)

  • 1. Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers.
    Žigrayová D; Mikušová V; Mikuš P
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.
    Islam N; Ferro V
    Nanoscale; 2016 Aug; 8(30):14341-58. PubMed ID: 27439116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Chitosan-Based Nanoparticles for Drug Delivery.
    Mikušová V; Mikuš P
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric nanoencapsulation of alpha interferon increases drug bioavailability and induces a sustained antiviral response in vivo.
    Pedroso-Santana S; Lamazares Arcia E; Fleitas-Salazar N; Gancino Guevara M; Mansilla R; Gómez-Gaete C; Altamirano C; Fernandez K; Ruiz A; Toledo Alonso JR
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111260. PubMed ID: 32806331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan Derivatives as Carriers for Drug Delivery and Biomedical Applications.
    Manna S; Seth A; Gupta P; Nandi G; Dutta R; Jana S; Jana S
    ACS Biomater Sci Eng; 2023 May; 9(5):2181-2202. PubMed ID: 37036371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment.
    Safer AM; Leporatti S
    Int J Nanomedicine; 2021; 16():8141-8158. PubMed ID: 34949922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan: An overview of biological activities, derivatives, properties, and current advancements in biomedical applications.
    Edo GI; Yousif E; Al-Mashhadani MH
    Carbohydr Res; 2024 Aug; 542():109199. PubMed ID: 38944980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric drugs: Advances in the development of pharmacologically active polymers.
    Li J; Yu F; Chen Y; Oupický D
    J Control Release; 2015 Dec; 219():369-382. PubMed ID: 26410809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles.
    Alhodieb FS; Barkat MA; Barkat HA; Hadi HA; Khan MI; Ashfaq F; Rahman MA; Hassan MZ; Alanezi AA
    Int J Biol Macromol; 2022 Sep; 217():457-469. PubMed ID: 35798082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
    Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
    Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.
    Chaudhury A; Das S
    AAPS PharmSciTech; 2011 Mar; 12(1):10-20. PubMed ID: 21153572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in chitosan-based blends as potential drug delivery systems: A review.
    Saadh MJ; Hsu CY; Mustafa MA; Mutee AF; Kaur I; Ghildiyal P; Ali AA; Adil M; Ali MS; Alsaikhan F; Narmani A; Farhood B
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):132916. PubMed ID: 38844287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article.
    Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Bustanji Y; Hamad I
    Curr Drug Targets; 2020; 21(15):1613-1624. PubMed ID: 32651965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research.
    Naskar S; Koutsu K; Sharma S
    J Drug Target; 2019 Apr; 27(4):379-393. PubMed ID: 30103626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-based Polymer Matrix for Pharmaceutical Excipients and Drug Delivery.
    Khan MIH; An X; Dai L; Li H; Khan A; Ni Y
    Curr Med Chem; 2019; 26(14):2502-2513. PubMed ID: 30259805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
    Agnihotri SA; Mallikarjuna NN; Aminabhavi TM
    J Control Release; 2004 Nov; 100(1):5-28. PubMed ID: 15491807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting polymer blending approach for fabrication of buccal chitosan-based composite sponges with augmented mucoadhesive characteristics.
    Freag MS; Saleh WM; Abdallah OY
    Eur J Pharm Sci; 2018 Jul; 120():10-19. PubMed ID: 29715500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomedical applications of natural and synthetic polymer based nanocomposites.
    A H; Sofini SPS; Balasubramanian D; Girigoswami A; Girigoswami K
    J Biomater Sci Polym Ed; 2024 Feb; 35(2):269-294. PubMed ID: 37962432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.